# K191557: CentriMag Acute Circulatory Support System

- Pathway: 510(k) (Special)
- Applicant: Thoratec Corporation (Now Part of Abbott)
- Decided: Jul 10, 2019 after 28 days
- Product code: DWA (Control, Pump Speed, Cardiopulmonary Bypass)
- Device class: 2
- Regulation: 21 CFR 870.4380
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K852698 (1985). 10 ancestors in all.
2 later devices descend from it; 1 cites it directly.
1 of 13 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K020271: Levitronix Centrimag Extracorporeal Blood Pumping System, Model L-100, Levitronix, LLC (2003) Summary page 5.
- K102129: Levitronix 2ND Generation Centrimag Primary Console, Levitronix Monitor, Levitronix, LLC (2010) Summary page 5.

## Most influential descendants
- K200306: CentriMag Circulatory Support System, CentriMag Return (Arterial) Cannula Kit, CentriMag Drainage (Venous) Cannula Kit (2020), 1 descendant of its own
- K234118: CentriMag™ Acute Circulatory Support System (2024), 0 descendants of its own

## Indications for use
The CentriMag Extracorporeal Blood Pumping System is indicated to pump blood through the extracorporeal bypass circuit for extracorporeal circulatory support for periods appropriate to cardiopulmonary bypass (up to six hours). It is also indicated for use in extracorporeal circulatory support systems (for periods up to six hours) not requiring complete cardiopulmonary bypass (e.g., valvuloplasty, circulatory support during mitral valve reoperation, surgery of the vena cava or aorta, liver transplants etc).

Source page: https://510kreport.com/device/K191557
Methodology: https://510kreport.com/methodology